234 related articles for article (PubMed ID: 30125071)
1. DHEA use to improve likelihood of IVF/ICSI success in patients with diminished ovarian reserve: A systematic review and meta-analysis.
Schwarze JE; Canales J; Crosby J; Ortega-Hrepich C; Villa S; Pommer R
JBRA Assist Reprod; 2018 Nov; 22(4):369-374. PubMed ID: 30125071
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection.
Li J; Yuan H; Chen Y; Wu H; Wu H; Li L
Int J Gynaecol Obstet; 2015 Dec; 131(3):240-5. PubMed ID: 26421833
[TBL] [Abstract][Full Text] [Related]
3. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
[TBL] [Abstract][Full Text] [Related]
4. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial.
Kotb MM; Hassan AM; AwadAllah AM
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():11-5. PubMed ID: 26963897
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.
Zhang M; Niu W; Wang Y; Xu J; Bao X; Wang L; Du L; Sun Y
J Assist Reprod Genet; 2016 Aug; 33(8):981-91. PubMed ID: 27094195
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis.
Zhang J; Jia H; Diao F; Ma X; Liu J; Cui Y
Front Endocrinol (Lausanne); 2023; 14():1156280. PubMed ID: 37361534
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
[TBL] [Abstract][Full Text] [Related]
8. The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis.
Qin JC; Fan L; Qin AP
J Gynecol Obstet Hum Reprod; 2017 Jan; 46(1):1-7. PubMed ID: 28403950
[TBL] [Abstract][Full Text] [Related]
9. Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review.
Tsui KH; Lin LT; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):131-6. PubMed ID: 25951716
[TBL] [Abstract][Full Text] [Related]
10. Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial.
Wang W; Liu H; Li J; Wei D; Zhang J; Wang J; Ma J; Shi Y; Chen ZJ
Trials; 2019 Jan; 20(1):50. PubMed ID: 30646929
[TBL] [Abstract][Full Text] [Related]
11. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.
Narkwichean A; Maalouf W; Campbell BK; Jayaprakasan K
Reprod Biol Endocrinol; 2013 May; 11():44. PubMed ID: 23680224
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
[TBL] [Abstract][Full Text] [Related]
14. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis.
Hamdan M; Dunselman G; Li TC; Cheong Y
Hum Reprod Update; 2015; 21(6):809-25. PubMed ID: 26168799
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Dehydroepiandrosterone (DHEA) Supplementation on IVF or ICSI: A Meta-Analysis of Randomized Controlled Trials.
Xu L; Hu C; Liu Q; Li Y
Geburtshilfe Frauenheilkd; 2019 Jul; 79(7):705-712. PubMed ID: 31303658
[No Abstract] [Full Text] [Related]
16. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
18. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
[TBL] [Abstract][Full Text] [Related]
19. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
[TBL] [Abstract][Full Text] [Related]
20. Does Dehydroepiandrosterone (DHEA) improve in vitro fertilisation (IVF) outcomes in poor responders?
Malini MN; Zain MM
Med J Malaysia; 2020 Jan; 75(1):24-28. PubMed ID: 32008015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
